Demand for pharmaceuticals and biotechnology products is on a continuous rise, fuelled by factors such as the emergence of scalable, personalised medicine, advancements in developing novel treatments, and the growing global population. The emphasis on personalised medicine is projected to drive significant growth between 2023 and 2030.
Additionally, the growing global population has challenged life science manufacturers to expedite drug development and market release, as seen by the approval of 71 novel treatments and vaccines in 2023 by the United States Food and Drug Administration (U.S. FDA) for various cancers and hard-to-treat diseases compared to only 45 approved in 2022. Moreover, many producers are expanding to new regions to mitigate risks associated with supply chain disruptions.
Whether the driver is speed, new market opportunities, or regionalising production, these trends highlight the importance of integrating advanced measurement instrumentation to ensure quality, control costs, and improve operational efficiency while navigating the accelerating biotech and pharmaceutical industries. This eBook examines various steps in the drug manufacturing process looking at the role instrumentation has in driving pipeline acceleration, flexible manufacturing, operational integrity, real-time release, and sustainable operation.
Learn how advanced measurement instrumentation can help optimise your drug manufacturing process within:
- Buffer and media preparation
- Fermentation
- Chromatography
- Filtration
- Utilities
Download the new eBook by Emerson.
https://connect.emerson.com/BiotechandPharmaceutical?utm_source=3rd_party_pub_euen-mfg_chemist&utm_medium=&utm_content=drift_ebook-adwb&utm_campaign=